YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson's COVID-19 vaccine added $502 million to its third-quarter revenue.
Revenue during the quarter was $23.3 billion, short of the $23.7 billion expected by analysts.
Adjusted earnings per share came to $2.60, beating the $2.35 per share estimate.
Read more from CNBC.
Organizers hope to bolster client traffic to center city businesses.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration